Whats new
Whats new.
Petra Capital - Immutep Ltd (IMM) - 3QFY23 – Clinical Progress on all fronts; Retain Buy, A$1.28 tgt (Analyst: Tanushree Jain)
April 28th 2023
For a copy of this analyst report please contact your Petra advisor
Whats new
April 28th 2023
For a copy of this analyst report please contact your Petra advisor